5 years of Critical Care EEGs
Transcription
5 years of Critical Care EEGs
5 years of Critical Care EEGs – 5 Lessons Learnt Dr Andrew Bailey (ST 6+ Anaethetics) Dr Larry Mulleague (Consultant Intensivistand Anesthetist) Epsom and St. Helier University NHS Trust Introduction Electroencephalography (EEG) is used in neuro-diagnostics of thecritically ill patient1 to - characterise paroxysmal clinical events (behavior, sensory perception, or motor activity) that might be seizures (abnormal neuronal activity). - detect non-convulsive or clinically subtle seizures - distinguish coma from diminished responsiveness due to other causes (psychiatric, sedation, neuromuscular, cortical de-efferentation/locked in syndrome) ILAE classification of seizures determines them to be eithergeneralised (bilateral), focal (unilateral) and focal with bilateral evolution. Epilepsy is defined as at least two unprovoked (or reflex) stereotyped attacks occurring more than 24 hours apart2.The assessment of neurologic dysfunction clinically is very difficult in the critically ill due to the presence of many metabolic /pharmacological factors altering consciousness (encephalopathic)&applying diuress to provoke seziures. Critical Care EEG can be helpful with certain syndromes - Metabolic - Anoxic - Infective - Toxic Aim 1) 2) 3) 4) 5) Identify percentage contribution of the above syndromes referred for EEG. Identify how EEG correlated or aided confirmation of the above syndromes. Assess the impact of repeat EEGs Identify risk factors for poor neurological outcome. Identifies areas of referral improvement Methods This was a retrospective study of DGH patients who underwent EEG monitoring over a 5-year period. Patientreferrals were classified into one of the following. Metabolic encephalopathy Anoxic encephalopathy Neurological infection Toxic encephalopathy Endocrine disorder Seizures (referral question does not elude to underlying pathology) Hypertensive encephalopathy Epilepsy Repeat The primary outcome measure was whether the report explicitly answered the referral question. Results Data from 1/4/2008 till 22/08/2014 excluding 1/4/2011 till 08/08/2012 due to missing data log. In total 60 months were studied yielding 71. Four however had noavailable EEG record therefore 67 studies were analysed with an average age of 52 years. Identify percentage contribution of the above syndromes referred for EEG. Most of referrals for EEG appear to be relating to seizures and anoxic encephalopathy, accounting for almost a third each. The next most common reason was as a repeat EEG (17%) and then metabolic encephalopathy (10%) and neurological infection (7%). Referal question Metabolic encephalopathy 10% Epilespy 2% Repeat 18% Toxic encephalopathy 3% Hypertensive encephalopathy 2% Anoxic encephalopathy 28% Seizures 30% Neurological infection 7% Identify how EEG results correlated or aided confirmation of the above syndromes. Anoxic encephalopathy; of nineteen cases only two reports explicitly confirmed anoxic encephalopathy. Fiveindirectly supported its diagnosis by the observation of triphasic and BIPED seizure activity and featureless EEGs. Four explicitly reported inconclusive test with two noting encephalopathy, one attributed to propofol. Five reports simplydescribed waveform activity with no application to the clinical picture. Nine of nineteen patients referred for EEG with the referral question of anoxic encephalopathy died. Half died within five days of the EEG where as the remaining patients took between 1-3 months. Six patients were referred for anoxic encephalopathy studies that had no history of CPR but four of these six patients had significant chest sepsis as primary critical care pathology. Seizure group; we once again see a heterogenic group of reports. - 4 inconclusive - 3 propofol encephalopathy - 4 encephalopathy - 3 anoxic encephalopathy - 4 waveform analysis with no reference to the clinical picture. - 1 syptomatic epilepsy but not status Repeat group, twelve cases in total. - 1minimal improvement - 1 repeated post propofol encephalopathy and noted grossly abnormal - 1 repeated post inconclusive result to confirm anoxic encephalopathy. - 9 were no change. Their initial reported syndromes being o 2 neurological infections o 4 anoxic encephalopathy o 3 were on the same patient regarding seizures where the initial EEG suggest anoxic encephalopthy Propofol grouponly one patient was re-tested of the four. Metabolic encephalopathy 2% Propofol encephalopathy 9% Reported Result No Change 18% Normal 2% Encephalopathy 16% Nil conclusive 29% Anoxic encephalopathy 13% Featureless 11% Conclusions As would be expected most EEGs were to aid the diagnosis of anoxic encephalopathy and seizures. The former requires clear communication between the referring team and with whom the EEG is analysed. With almost a quarter of these reports simply having waveform analyse this may prove a barrier to the intensivist’s application of the result with the patients future care pathway. EEGs have no role in the determination of brain death. It is a surface brain study and therefore limited in its ability at describing brain stem activity. An iso -electric or wholly unreactive EEG however may aid relatives in acknowledging futility1 . Patientslabelled as seizure with no explicit neurological syndrome documented,demonstrated no incidence of status. Understandably a third of these patients’ reports were inconclusive or once again were solely waveform analysis. One patient was referred to aid the diagnosis of epilepsy. Noting epilepsy’s definition being two unprovoked seizures and the average critical care phenotype often possessing several provoking factors, one must question the usefulness of such a referral. Abnormal movements often pose the intensivista diagnostic challenge. Grimacing, chewing, or nystagmoid eye movements; abrupt and otherwise unexplained changes in pulse, blood pressure or respiratory pattern; or abrupt deterioration in conscious level may all be clinical events caused by abnormal neuronal activity (seizures)1. The greatest fear is to miss non-convulsive status eplilptics (NCSE), which should be anticipated in those with a prior history of epilepsy, any intracranial event or infection. Our study however shows that NSCE has an incidence of less than 1in70 patients referred for EEG. One otherfinding that may have an impact on future patient management concerns those patients reported as propofol encephalopathy. Only one had a repeat study, which questions the necessity of the initial referral. Those patients who did undergo a repeated EEG on the whole had no change in report. No change should still be seen as a positive result as it adds weight to the initial EEG findings. Risk factors for poor neurological outcome, seem to be those patients who have received CPR but also those with significant chest sepsis. Areas of referral improvement identified were a. Explicit questions in the referral. b. Tick box for poor neurological outcome risk factors c. Post-EEG one on one discussion between consultants (e.g. gastroenterologist doing an urgent OGD or radiologist interrupting a critical care CT) References 1. SJM Smith, EEG in neurological conditions other than epilepsy: when does it help, what does it add? J NeurolNeurosurg Psychiatry 2005;76:ii8-ii12 2. SJM Smith, EEG in the diagnosis, classification, and management of patients with epilepsy. J NeurolNeurosurg Psychiatry 2005;76:ii2-ii7